NELSON
Between the jury's staggering $417 million Johnson & Johnson verdict and the judge's complete rejection of it in a bellwether trial, only one thing has been certain in the talc litigation: Expect the unexpected.
Just two months ago, the pharmaceutical giant was staring down the barrel of a fifth trial loss related to its baby powder product after a California jury found in favor of cancer-stricken plaintiff Eva Echeverria, who ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




